Drug Slows Cognitive Impairment in Multiple Sclerosis
Spectrum Science CommunicationsA new study published in the Annals of Neurology shows that treatment with interferon beta-1a, or Avonex, has a significant beneficial effect on the cognitive impairment often suffered by people with relapsing multiple sclerosis (MS).